HCM Academy is an online educational programme that targets developing measurable improvement in clinician understanding, skills, and confidence around hypertrophic cardiomyopathy (HCM) diagnosis and management.

Although common, HCM is often under-diagnosed and under-managed, significantly worsening the outcomes for patients and profoundly impacting their lives and families.

The HCM Academy programme was developed to raise awareness of HCM and its management with healthcare professionals. The primary objective was to support identification, timely diagnosis and management of patients with HCM in order to improve patient outcomes.

Our approach

The 2023 programme, delivered by our CME division, PCM Scientific, was developed in partnership with a leading expert faculty from the US and Europe, with support from the steering committee and the Hypertrophic Cardiomyopathy Association (HCMA).

For primary care clinicians, the focus was on providing education and awareness about HCM topics, such as how to identify HCM, while for secondary care, we highlighted important issues and specialist considerations in its management. We delivered a series of live webinars throughout the year, with corresponding online case studies providing practical insights and content tailored specifically to primary and secondary care audiences.

Each webinar was then available to watch on-demand for free via the HCM Academy website. In addition, free online resources, including modules, case studies, and patient stories, were on offer, providing greater insight into key HCM topics.

Cogora assumed responsibility for all aspects of programme concept/branding, speaker/faculty management and liaison, content development, website development, design of marketing assets, and recruitment/promotion.

Recruitment for the webinars and promotion of the on-demand resources was done via our media brands, Pulse, Nursing in Practice, Hospital Pharmacist Europe, and Hospital Healthcare Europe, targeting family practitioners, primary care physicians, nurse practitioners, advanced practice providers, GPs, and community cardiology teams across Europe, the US, and Canada.

Marketing included a combination of targeted emails, social media, online advertising, advertising through our partnership with the HCMA, and marketing outreach through regional educators’ marketing centres. Our marketing team worked closely with PCM Scientific and our Studio team to develop targeted marketing assets designed to engage the target audiences.


  • 205,000+ views of the HCM platform during 2023
  • 60,000+ engaged learning sessions
  • 20 CME webinars delivered

The 2023 HCM Academy programme has received fantastic engagement and feedback from learners:

  • “Excellent presentation with easy to understand and remember the key messages”
  • “Great information to upskill and refresh”
  • “All your topics are wonderful.”
  • “Excellent webinar, relatable and enjoyable”

92% of users agreed they have gained knowledge that will ‘contribute to knowledge, skills, and attitude to enhance the delivery of patient care’ and 99% would recommend the education to other healthcare providers.

These fantastic results demonstrate the validity of the tactical recommendations made by Cogora, evidencing our deep understanding of how to engage HCPs, and our unrivalled access via our media brands.

The on-demand resources are available on the HCM Academy website, available for HCPs to access at their convivence and gain CE credit(s).


HCM Academy is supported by an educational grant funding from Bristol Myers Squibb, Cytokinetics, Sanofi and Tenaya Therapeutics. PCM Scientific is the medical education company acting as scientific secretariat and organiser for this program. All content is created by the faculty and no funder has had input into any content. All activity is run independently of the funders.